Repligen Corp
NASDAQ:RGEN
Repligen Corp
NASDAQ:RGEN
Price:
158.36 USD
-3.56%
Market Closed
Updated:
May 2, 2024
Repligen Corp
Operating Income
|
Repligen Corp
Operating Income Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Repligen Corp
NASDAQ:RGEN
|
Operating Income
$86.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
25%
|
CAGR 10-Years
14%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Income
$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Operating Income
$9.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Income
$1.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Income
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Income
$2.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is Repligen Corp's Operating Income?
Operating Income
86.8m
USD
86.8m
USD
Based on the financial report for Dec 31, 2023, Repligen Corp's Operating Income amounts to 86.8m USD.
What is Repligen Corp's Operating Income growth rate?
Operating Income CAGR 10Y
14%
14%
Over the last year, the Operating Income growth was -56%. The average annual Operating Income growth rates for Repligen Corp have been 6% over the past three years , 25% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
